$AXON
AXON ENTERPRISE, INC.

2022 Q2 Form 10-Q Financial Statement

#000155837022008142 Filed on May 10, 2022

View on sec.gov

Income Statement

Concept 2022 Q2 2022 Q1 2021 Q4
Revenue $285.6M $256.4M $217.6M
YoY Change 30.54% 31.49% -3.77%
Cost Of Revenue $111.7M $100.7M $82.52M
YoY Change 38.07% 40.49% -2.69%
Gross Profit $174.0M $155.7M $135.1M
YoY Change 26.13% 26.25% -4.42%
Gross Profit Margin 60.91% 60.73% 62.07%
Selling, General & Admin $95.01M $90.13M $111.5M
YoY Change -46.52% -28.81% 14.31%
% of Gross Profit 54.61% 57.87% 82.52%
Research & Development $57.55M $48.42M $50.67M
YoY Change 6.66% 2.97% 33.35%
% of Gross Profit 33.08% 31.09% 37.52%
Depreciation & Amortization $6.210M $5.755M $5.274M
YoY Change 44.69% 34.12% 48.98%
% of Gross Profit 3.57% 3.7% 3.9%
Operating Expenses $152.6M $138.5M $162.1M
YoY Change -34.14% -20.2% 19.56%
Operating Profit $21.41M $17.19M -$27.07M
YoY Change -122.85% -134.21% -574.84%
Interest Expense $47.03M $55.30M -$10.15M
YoY Change 12.39% 9352.82% -407.52%
% of Operating Profit 219.63% 321.62%
Other Income/Expense, Net
YoY Change
Pretax Income $68.44M $72.49M -$37.21M
YoY Change -232.01% -245.93% -513.49%
Income Tax $17.48M $17.62M -$23.71M
% Of Pretax Income 25.53% 24.31%
Net Earnings $50.96M $54.87M -$13.51M
YoY Change -208.16% -214.51% -152.36%
Net Earnings / Revenue 17.84% 21.4% -6.21%
Basic Earnings Per Share $0.72 $0.77
Diluted Earnings Per Share $705.0K $0.76 -$194.8K
COMMON SHARES
Basic Shares Outstanding 71.01M 70.95M 68.47M
Diluted Shares Outstanding 72.28M 72.35M

Balance Sheet

Concept 2022 Q2 2022 Q1 2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $377.2M $444.0M $428.5M
YoY Change -42.43% -25.47% -23.75%
Cash & Equivalents $212.8M $386.4M $356.3M
Short-Term Investments $164.4M $57.60M $72.18M
Other Short-Term Assets $61.84M $67.21M $56.54M
YoY Change 36.04% 55.94% 53.22%
Inventory $154.3M $122.2M $108.7M
Prepaid Expenses
Receivables $576.4M $492.8M $501.2M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $1.170B $1.146B $1.109B
YoY Change 8.22% 16.21% 12.99%
LONG-TERM ASSETS
Property, Plant & Equipment $154.7M $149.5M $138.5M
YoY Change 29.02% 33.34% 31.25%
Goodwill $43.61M $43.59M
YoY Change 73.08% 72.95%
Intangibles $14.40M $15.47M
YoY Change 66.62% 63.74%
Long-Term Investments $306.6M $172.2M $114.8M
YoY Change 186.05% 119.34% 12.06%
Other Assets $204.7M $98.00M $98.25M
YoY Change 142.99% -4.78% 44.04%
Total Long-Term Assets $762.2M $626.3M $578.7M
YoY Change 70.92% 49.62% 45.02%
TOTAL ASSETS
Total Short-Term Assets $1.170B $1.146B $1.109B
Total Long-Term Assets $762.2M $626.3M $578.7M
Total Assets $1.932B $1.772B $1.688B
YoY Change 26.53% 26.17% 22.24%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $60.69M $49.35M $32.22M
YoY Change 680.26% 149.35% 33.46%
Accrued Expenses $94.56M $69.44M $103.7M
YoY Change 41.33% 68.95% 73.3%
Deferred Revenue $326.6M $265.6M
YoY Change 97.85% 61.99%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $433.0M $470.7M $418.5M
YoY Change 58.67% 96.3% 63.27%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $305.4M $4.593M $5.392M
YoY Change 843.76% -83.52% -80.27%
Total Long-Term Liabilities $305.4M $4.593M $5.392M
YoY Change 843.76% -83.52% -80.27%
TOTAL LIABILITIES
Total Short-Term Liabilities $433.0M $470.7M $418.5M
Total Long-Term Liabilities $305.4M $4.593M $5.392M
Total Liabilities $738.4M $647.7M $640.4M
YoY Change 72.04% 64.4% 58.2%
SHAREHOLDERS EQUITY
Retained Earnings $164.8M $109.9M
YoY Change 35.06% -35.33%
Common Stock $1.119B $1.095B
YoY Change 7.1% 13.83%
Preferred Stock
YoY Change
Treasury Stock (at cost) $155.9M $155.9M
YoY Change 0.0% 0.0%
Treasury Stock Shares $20.22M $20.22M
Shareholders Equity $1.194B $1.125B $1.048B
YoY Change
Total Liabilities & Shareholders Equity $1.932B $1.772B $1.688B
YoY Change 26.53% 26.17% 22.24%

Cashflow Statement

Concept 2022 Q2 2022 Q1 2021 Q4
OPERATING ACTIVITIES
Net Income $50.96M $54.87M -$13.51M
YoY Change -208.16% -214.51% -152.36%
Depreciation, Depletion And Amortization $6.210M $5.755M $5.274M
YoY Change 44.69% 34.12% 48.98%
Cash From Operating Activities $19.38M $43.96M $12.93M
YoY Change -43.3% -27.86% -62.33%
INVESTING ACTIVITIES
Capital Expenditures -$12.82M $17.10M -$13.62M
YoY Change -5.86% 62.51% 104.2%
Acquisitions
YoY Change
Other Investing Activities -$175.6M $6.787M $172.8M
YoY Change -286.47% -115.58% -448.53%
Cash From Investing Activities -$188.4M -$10.35M $159.1M
YoY Change -333.89% -80.88% -382.97%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -934.0K -1.459M -97.28M
YoY Change -71.37% -79.29% 10473.8%
NET CHANGE
Cash From Operating Activities 19.38M 43.96M 12.93M
Cash From Investing Activities -188.4M -10.35M 159.1M
Cash From Financing Activities -934.0K -1.459M -97.28M
Net Change In Cash -170.0M 32.00M 74.79M
YoY Change -252.49% -5252.98% -427.47%
FREE CASH FLOW
Cash From Operating Activities $19.38M $43.96M $12.93M
Capital Expenditures -$12.82M $17.10M -$13.62M
Free Cash Flow $32.19M $26.87M $26.55M
YoY Change -32.64% -46.71% -35.23%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001069183
CY2022Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q1 dei Amendment Flag
AmendmentFlag
false
CY2022Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
70996658
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
70896856
CY2022Q1 dei Trading Symbol
TradingSymbol
AXON
CY2022Q1 dei Document Type
DocumentType
10-Q
CY2022Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q1 dei Entity File Number
EntityFileNumber
001-16391
CY2022Q1 dei Entity Registrant Name
EntityRegistrantName
Axon Enterprise, Inc.
CY2022Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
86-0741227
CY2022Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
17800 North 85th Street
CY2022Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Scottsdale
CY2022Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
AZ
CY2022Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
85255
CY2022Q1 dei City Area Code
CityAreaCode
480
CY2022Q1 dei Local Phone Number
LocalPhoneNumber
991-0797
CY2022Q1 dei Security12b Title
Security12bTitle
Common Stock, $0.00001 Par Value
CY2022Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2022Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2022Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q1 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
71011451
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
386367000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
356332000
CY2022Q1 us-gaap Marketable Securities
MarketableSecurities
57600000
CY2021Q4 us-gaap Marketable Securities
MarketableSecurities
72180000
CY2022Q1 us-gaap Short Term Investments
ShortTermInvestments
20024000
CY2021Q4 us-gaap Short Term Investments
ShortTermInvestments
14510000
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2424000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2203000
CY2022Q1 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
344907000
CY2021Q4 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
320819000
CY2022Q1 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
147861000
CY2021Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
180421000
CY2022Q1 us-gaap Inventory Net
InventoryNet
122150000
CY2021Q4 us-gaap Inventory Net
InventoryNet
108688000
CY2022Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
67208000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
56540000
CY2022Q1 us-gaap Assets Current
AssetsCurrent
1146117000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
1109490000
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
149505000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
138457000
CY2022Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
108840000
CY2021Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
127193000
CY2022Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
14399000
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
15470000
CY2022Q1 us-gaap Goodwill
Goodwill
43607000
CY2021Q4 us-gaap Goodwill
Goodwill
43592000
CY2022Q1 us-gaap Long Term Investments
LongTermInvestments
17731000
CY2021Q4 us-gaap Long Term Investments
LongTermInvestments
31232000
CY2022Q1 us-gaap Long Term Accounts Notes And Loans Receivable Net Noncurrent
LongTermAccountsNotesAndLoansReceivableNetNoncurrent
10184000
CY2021Q4 us-gaap Long Term Accounts Notes And Loans Receivable Net Noncurrent
LongTermAccountsNotesAndLoansReceivableNetNoncurrent
11256000
CY2022Q1 us-gaap Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
29616000
CY2021Q4 us-gaap Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
29753000
CY2022Q1 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
154452000
CY2021Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
83520000
CY2022Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
98003000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
98247000
CY2022Q1 us-gaap Assets
Assets
1772454000
CY2021Q4 us-gaap Assets
Assets
1688210000
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
49348000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
32220000
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
69435000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
103707000
CY2022Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
326627000
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
265591000
CY2022Q1 axon Customer Deposit Current
CustomerDepositCurrent
18411000
CY2021Q4 axon Customer Deposit Current
CustomerDepositCurrent
10463000
CY2022Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
6858000
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
6540000
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
470679000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
418521000
CY2022Q1 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
140938000
CY2021Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
185721000
CY2022Q1 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
5162000
CY2021Q4 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
3797000
CY2022Q1 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
5833000
CY2021Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
5679000
CY2022Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
348000
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
811000
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
20112000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
20440000
CY2022Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
4593000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5392000
CY2022Q1 us-gaap Liabilities
Liabilities
647665000
CY2021Q4 us-gaap Liabilities
Liabilities
640361000
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
64036000
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
72349000
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
64036000
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
70996658
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
70896856
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
1000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
1000
CY2022Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1118859000
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1095229000
CY2022Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
20220227
CY2021Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
20220227
CY2022Q1 us-gaap Treasury Stock Value
TreasuryStockValue
155947000
CY2021Q4 us-gaap Treasury Stock Value
TreasuryStockValue
155947000
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
164754000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
109883000
CY2022Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2878000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1317000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
1124789000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
1047849000
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1772454000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1688210000
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
256426000
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
195019000
CY2022Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
100687000
CY2021Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
71666000
CY2022Q1 us-gaap Gross Profit
GrossProfit
155739000
CY2021Q1 us-gaap Gross Profit
GrossProfit
123353000
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
90129000
CY2021Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
126597000
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
48416000
CY2021Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
47018000
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
138545000
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
173615000
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
17194000
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-50262000
CY2022Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
55299000
CY2021Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
585000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
72493000
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-49677000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
17622000
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1760000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
54871000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-47917000
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.77
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.75
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.76
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.75
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
70950000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
54871000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-47917000
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1072000
CY2021Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1000
CY2022Q1 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-489000
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
53310000
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-47916000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
1047849000
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
-70000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
-1388000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
25088000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
54871000
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1561000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
1124789000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
976255000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
-7045000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
89610000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-47917000
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
1010904000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
54871000
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-47917000
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5755000
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4291000
CY2022Q1 us-gaap Gain Loss On Disposition Of Intangible Assets
GainLossOnDispositionOfIntangibleAssets
-40000
CY2021Q1 us-gaap Gain Loss On Disposition Of Intangible Assets
GainLossOnDispositionOfIntangibleAssets
-11000
CY2022Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-106000
CY2021Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-45000
CY2022Q1 us-gaap Gain Loss On Investments
GainLossOnInvestments
55851000
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
25088000
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
89610000
CY2022Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
18029000
CY2021Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-598000
CY2022Q1 axon Provision For Unrecognized Tax Benefits
ProvisionForUnrecognizedTaxBenefits
1365000
CY2021Q1 axon Provision For Unrecognized Tax Benefits
ProvisionForUnrecognizedTaxBenefits
194000
CY2022Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
159000
CY2021Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1504000
CY2022Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
1556000
CY2021Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
1111000
CY2022Q1 axon Credit Loss Reserve
CreditLossReserve
228000
CY2021Q1 axon Credit Loss Reserve
CreditLossReserve
-335000
CY2022Q1 us-gaap Increase Decrease In Accounts And Notes Receivable
IncreaseDecreaseInAccountsAndNotesReceivable
-7495000
CY2021Q1 us-gaap Increase Decrease In Accounts And Notes Receivable
IncreaseDecreaseInAccountsAndNotesReceivable
-31298000
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
14260000
CY2021Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-520000
CY2022Q1 axon Increase Decrease In Prepaid Expense And Other Current Assets
IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets
7074000
CY2021Q1 axon Increase Decrease In Prepaid Expense And Other Current Assets
IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets
6952000
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-9580000
CY2021Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-18062000
CY2022Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
16037000
CY2021Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
6219000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
43964000
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
60939000
CY2021Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
155825000
CY2022Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
7200000
CY2021Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
132254000
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
17098000
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
10521000
CY2022Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
87000
CY2021Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
10000
CY2022Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
37000
CY2021Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
41000
CY2022Q1 axon Payments To Acquire Equity Securities Without Readily Determinable Fair Value
PaymentsToAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue
500000
CY2021Q1 axon Payments To Acquire Equity Securities Without Readily Determinable Fair Value
PaymentsToAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue
20000000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-10348000
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-54123000
CY2022Q1 axon Net Proceeds From Equity Offering
NetProceedsFromEquityOffering
-71000
CY2022Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1388000
CY2021Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
7045000
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1459000
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-7045000
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-157000
CY2021Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-392000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
32000000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-621000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
356438000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
155551000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
388438000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
154930000
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
386367000
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
154822000
CY2022Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
2071000
CY2021Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
108000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
388438000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
154930000
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
334000
CY2021Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
4152000
CY2022Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
888000
CY2021Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
517000
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
64036000
CY2021Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
2822000
CY2022Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
54871000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-47917000
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
70950000
CY2022Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1399000
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
72349000
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
64036000
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2942000
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
12234000
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.77
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.75
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.76
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.75
CY2022Q1 axon Warranty Period After Purchase Of Product
WarrantyPeriodAfterPurchaseOfProduct
P1Y
CY2020Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
769000
CY2022Q1 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
1434000
CY2021Q1 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
231000
CY2022Q1 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
116000
CY2021Q1 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
406000
CY2022Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
1504000
CY2021Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
944000
CY2022Q1 us-gaap Cash Surrender Value Fair Value Disclosure
CashSurrenderValueFairValueDisclosure
4900000
CY2021Q4 us-gaap Cash Surrender Value Fair Value Disclosure
CashSurrenderValueFairValueDisclosure
5300000
CY2022Q1 axon Investments In Number Of Affiliates
InvestmentsInNumberOfAffiliates
4
CY2022Q1 us-gaap Restricted Cash
RestrictedCash
2100000
CY2021Q4 us-gaap Restricted Cash
RestrictedCash
100000
CY2022Q1 us-gaap Reclassifications
Reclassifications
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Reclassification of Prior Year Presentation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Certain prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications are not material and had no effect on the reported results of operations.</p>
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
256426000
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
195019000
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
256426000
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
195019000
CY2022Q1 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
177477000
CY2022Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
467565000
CY2022Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
104043000
CY2022Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
326627000
CY2022Q1 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
140938000
CY2022Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
467565000
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
265591000
CY2021Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
185721000
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
451312000
CY2022Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
326627000
CY2022Q1 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
140938000
CY2022Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
467565000
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
265591000
CY2021Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
185721000
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
451312000
CY2021Q4 us-gaap Cash Surrender Value Fair Value Disclosure
CashSurrenderValueFairValueDisclosure
5276000
CY2022Q1 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
55114000
CY2021Q4 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
54028000
CY2021Q4 us-gaap Marketable Securities
MarketableSecurities
72180000
CY2021Q4 axon Short Term Investment
ShortTermInvestment
14510000
CY2021Q4 axon Long Term Investment
LongTermInvestment
31232000
CY2022Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
2970000000
CY2022Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
515026000
CY2022Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
1000
CY2022Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
33305000
CY2022Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
481722000
CY2022Q1 axon Cash Cash Equivalent And Investments Amortized Cost
CashCashEquivalentAndInvestmentsAmortizedCost
386367000
CY2022Q1 us-gaap Marketable Securities
MarketableSecurities
57600000
CY2022Q1 axon Short Term Investment
ShortTermInvestment
20024000
CY2022Q1 axon Long Term Investment
LongTermInvestment
17731000
CY2021Q4 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
492350000
CY2021Q4 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Gain
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
5000
CY2021Q4 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Loss
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
18101000
CY2021Q4 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
474254000
CY2021Q4 axon Cash Cash Equivalent And Investments Amortized Cost
CashCashEquivalentAndInvestmentsAmortizedCost
356332000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
3349000
CY2022Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
228000
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
137000
CY2022Q1 axon Allowance For Doubtful Accounts Receivable Other
AllowanceForDoubtfulAccountsReceivableOther
-2000
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
3438000
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2424000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2203000
CY2022Q1 us-gaap Contract With Customer Asset Accumulated Allowance For Credit Loss
ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss
891000
CY2021Q4 us-gaap Contract With Customer Asset Accumulated Allowance For Credit Loss
ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss
1010000
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable Noncurrent
AllowanceForDoubtfulAccountsReceivableNoncurrent
123000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Noncurrent
AllowanceForDoubtfulAccountsReceivableNoncurrent
136000
CY2022Q1 axon Allowance For Expected Credit Losses On Customer Receivables
AllowanceForExpectedCreditLossesOnCustomerReceivables
3438000
CY2021Q4 axon Allowance For Expected Credit Losses On Customer Receivables
AllowanceForExpectedCreditLossesOnCustomerReceivables
3349000
CY2022Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
42452000
CY2021Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
38267000
CY2022Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
79698000
CY2021Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
70421000
CY2022Q1 us-gaap Inventory Net
InventoryNet
122150000
CY2021Q4 us-gaap Inventory Net
InventoryNet
108688000
CY2022Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
212972000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
197241000
CY2022Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
63467000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
58784000
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
149505000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
138457000
CY2021Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
83520000
CY2022Q1 axon Equity Securities Without Readily Determinable Fair Value Purchases
EquitySecuritiesWithoutReadilyDeterminableFairValuePurchases
500000
CY2022Q1 axon Equity Securities Without Readily Determinable Fair Value Increase
EquitySecuritiesWithoutReadilyDeterminableFairValueIncrease
70432000
CY2022Q1 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
154452000
axon Equity Securities Without Readily Determinable Fair Value Purchases
EquitySecuritiesWithoutReadilyDeterminableFairValuePurchases
55656000
axon Equity Securities Without Readily Determinable Fair Value Increase
EquitySecuritiesWithoutReadilyDeterminableFairValueIncrease
113342000
axon Equity Securities Without Readily Determinable Fair Value Sales
EquitySecuritiesWithoutReadilyDeterminableFairValueSales
14546000
CY2022Q1 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
154452000
CY2022Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
70400000
CY2022Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
1504000
CY2021Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
2822000
CY2022Q1 us-gaap Cash Surrender Value Fair Value Disclosure
CashSurrenderValueFairValueDisclosure
4912000
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
7152000
CY2022Q1 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
56000
CY2021Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
57000
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
23242000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
23270000
CY2022Q1 axon Deferred Implementation Costs
DeferredImplementationCosts
3697000
CY2021Q4 axon Deferred Implementation Costs
DeferredImplementationCosts
3915000
CY2022Q1 axon Prepaid Expenses Deposits And Other Assets Noncurrent
PrepaidExpensesDepositsAndOtherAssetsNoncurrent
10982000
CY2021Q4 axon Prepaid Expenses Deposits And Other Assets Noncurrent
PrepaidExpensesDepositsAndOtherAssetsNoncurrent
11701000
CY2022Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
98003000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
98247000
CY2021 axon Deferred Implementation Costs Assets Placed Into Service
DeferredImplementationCostsAssetsPlacedIntoService
4300000
CY2022Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
33242000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
62425000
CY2022Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
6982000
CY2022Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
3615000
CY2021Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
3736000
CY2022Q1 axon Accrued Inventory In Transit Current
AccruedInventoryInTransitCurrent
8910000
CY2021Q4 axon Accrued Inventory In Transit Current
AccruedInventoryInTransitCurrent
9945000
CY2022Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
15182000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
17627000
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
69435000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
103707000
CY2022Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
108500000
CY2022Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
18900000
CY2022Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
18900000
CY2022Q1 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
12800000
CY2022Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.243
CY2022Q1 us-gaap Effective Income Tax Rate Reconciliation Tax Contingencies
EffectiveIncomeTaxRateReconciliationTaxContingencies
0.257
CY2022Q1 axon Effective Income Tax Rate Reconciliation Deduction Stockbased Compensation
EffectiveIncomeTaxRateReconciliationDeductionStockbasedCompensation
1100000
CY2018Q2 axon Market Capitalization Goal For Tranche First Tranche
MarketCapitalizationGoalForTrancheFirstTranche
2500000000
CY2018Q2 axon Market Capitalization Goal For Tranche Incremental Increase
MarketCapitalizationGoalForTrancheIncrementalIncrease
1000000000.0
CY2022Q1 axon Revenue Goal Goal Number One
RevenueGoalGoalNumberOne
710058000
CY2022Q1 axon Adjusted Ebitda Goal Goal Number One
AdjustedEbitdaGoalGoalNumberOne
125000000
CY2022Q1 axon Revenue Goal Goal Number Two
RevenueGoalGoalNumberTwo
860058000
CY2022Q1 axon Adjusted Ebitda Goal Goal Number Two
AdjustedEbitdaGoalGoalNumberTwo
155000000
CY2022Q1 axon Revenue Goal Goal Number Three
RevenueGoalGoalNumberThree
1010058000
CY2022Q1 axon Adjusted Ebitda Goal Goal Number Three
AdjustedEbitdaGoalGoalNumberThree
175000000
CY2022Q1 axon Revenue Goal Goal Number Four
RevenueGoalGoalNumberFour
1210058000
CY2022Q1 axon Adjusted Ebitda Goal Goal Number Four
AdjustedEbitdaGoalGoalNumberFour
190000000
CY2022Q1 axon Revenue Goal Goal Number Five
RevenueGoalGoalNumberFive
1410058000
CY2022Q1 axon Adjusted Ebitda Goal Goal Number Five
AdjustedEbitdaGoalGoalNumberFive
200000000
CY2022Q1 axon Revenue Goal Goal Number Six
RevenueGoalGoalNumberSix
1610058000
CY2022Q1 axon Adjusted Ebitda Goal Goal Number Six
AdjustedEbitdaGoalGoalNumberSix
210000000
CY2022Q1 axon Revenue Goal Goal Number Seven
RevenueGoalGoalNumberSeven
1810058000
CY2022Q1 axon Adjusted Ebitda Goal Goal Number Seven
AdjustedEbitdaGoalGoalNumberSeven
220000000
CY2022Q1 axon Revenue Goal Goal Number Eight
RevenueGoalGoalNumberEight
2010058000
CY2022Q1 axon Adjusted Ebitda Goal Goal Number Eight
AdjustedEbitdaGoalGoalNumberEight
230000000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
233100000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
1100000
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
25088000
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
89610000
CY2022Q1 axon Maximum Ratio Of Liabilities To Tangible Net Worth
MaximumRatioOfLiabilitiesToTangibleNetWorth
2.50
CY2022Q1 us-gaap Loss Contingency Pending Claims Number
LossContingencyPendingClaimsNumber
3
CY2022Q1 axon Product Claims Self Insurance
ProductClaimsSelfInsurance
5000000.0
CY2022Q1 axon Employee Deferrals Vested Percentage
EmployeeDeferralsVestedPercentage
1
CY2022Q1 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
3100000
CY2021Q1 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
2100000
CY2022Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
256426000
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
195019000
CY2022Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
100687000
CY2021Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
71666000
CY2022Q1 us-gaap Gross Profit
GrossProfit
155739000
CY2021Q1 us-gaap Gross Profit
GrossProfit
123353000
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
48416000
CY2021Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
47018000

Files In Submission

Name View Source Status
0001558370-22-008142-index-headers.html Edgar Link pending
0001558370-22-008142-index.html Edgar Link pending
0001558370-22-008142.txt Edgar Link pending
0001558370-22-008142-xbrl.zip Edgar Link pending
axon-20220331.xsd Edgar Link pending
axon-20220331x10q.htm Edgar Link pending
axon-20220331x10q_htm.xml Edgar Link completed
axon-20220331xex10d1.htm Edgar Link pending
axon-20220331xex31d1.htm Edgar Link pending
axon-20220331xex31d2.htm Edgar Link pending
axon-20220331xex32.htm Edgar Link pending
axon-20220331_cal.xml Edgar Link unprocessable
axon-20220331_def.xml Edgar Link unprocessable
axon-20220331_lab.xml Edgar Link unprocessable
axon-20220331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending